Mesothelioma News and Research

RSS
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.
Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

International researchers succeed in stopping growth of mesothelioma in model animals

International researchers succeed in stopping growth of mesothelioma in model animals

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Molecular inhibitors found to arrest tumor cell proliferation in lung cancer and mesothelioma

Molecular inhibitors found to arrest tumor cell proliferation in lung cancer and mesothelioma

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study findings could lead to less expensive and more effective cancer treatments

Study findings could lead to less expensive and more effective cancer treatments

Novel approach could help predict how well patients respond to cancer treatment

Novel approach could help predict how well patients respond to cancer treatment

New report highlights global burden of pollution-related disease and death

New report highlights global burden of pollution-related disease and death

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

New clinical trial offers hope for patients with hard-to-treat cancer caused by asbestos

New clinical trial offers hope for patients with hard-to-treat cancer caused by asbestos

Scientists establish process for identifying biomarkers for cancer diagnosis

Scientists establish process for identifying biomarkers for cancer diagnosis

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

Global experts meet at IASLC 17th World Conference on Lung Cancer in Vienna

Global experts meet at IASLC 17th World Conference on Lung Cancer in Vienna

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin